Evidence map›Paper›PMID 36805799›Full record

ArticleJournal of ovarian research2023

LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC.

Di Sun, Yining Wang, Ningxia Sun, Zhongxin Jiang, Ziyuan Li, Liang Wang, Fu Yang, Wen Li

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. The Implications of Alternative Splicing Regulation for Maximum Lifespan.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Influence of Long Non-Coding RNAs on Human Oocyte Development.Pharmacogenomics and personalized medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Di Sun *Center for Reproductive Medicine & Fertility Preservation Program, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yining Wang *The Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Ningxia Sun *The Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Zhongxin JiangThe Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Ziyuan LiThe Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Liang WangThe Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Fu YangThe Center of Reproductive Medicine, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, 200003, China. yangfusq1997@smmu.edu.cn.
Wen LiCenter for Reproductive Medicine & Fertility Preservation Program, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, China. liwen@shsmu.edu.cn.
Shanghai Changzheng Hospital · CNInternational Peace Maternity & Child Health Hospital · CN

Funding

Innovative Research Team of High-Level Local Universities in Shanghai SHSMU-ZDCX20212200National Key R&D Program of China 2018YFC1002802National Natural Science Foundation of China 82271662, 81873821, 82071605
6 · The paper itself

Abstract

backgroundPremature ovarian insufficiency (POI) is one of the common women reproductive endocrine diseases which adversely impacts female fertility, but the etiology and pathogenesis still remain elusive. Recently increasing researches focus on the roles of lncRNA in POI. LncRNA DANCR was involved in cell differentiation and multiple cancers. It's highly expressed in ovary while the role of DANCR in POI is still unknown.

resultsHere, we identify a new POI related lncRNA DANCR, which negatively contributes to ovarian granulosa cells aging and follicular atresia. DANCR is proved to be decreasingly expressed in POI patients' granulosa cells. Additionally, Dancr knockout (Dancr

conclusionThe newly identified lncRNA DANCR inhibits p53-dependent granulosa cells aging by regulating hNRNPC-p53 interaction, and eventually counteracting POI. This provides new insights into the pathogenesis of POI and provides a potential target for future diagnosis and treatment.

Indexed as

Menopause, PrematurePrimary Ovarian InsufficiencyRNA, Long NoncodingAnimalsFemaleFollicular AtresiaGranulosa CellsHeterogeneous-Nuclear Ribonucleoprotein Group CHumansMiceTumor Suppressor Protein p53Heterogeneous-Nuclear Ribonucleoprotein Group CHNRNPC protein, humanRNA, Long NoncodingTumor Suppressor Protein p53DANCRGranulosa cell aginghNRNPCp53Premature ovarian insufficiency

Identifiers

PMID36805799
PMCPMC9938559
OpenAlexW4321243177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.